Revenue
0 USD
2026 Q2 · USD
Exact inputs and evidence
- Revenue: 0 USD Source
Fundies. English
MAGNA LAB INC
EDGARAnnual consolidated revenue for 2025: about USD 12.35K, using the latest reported figures. The previous period, 2024, was about USD 3.47K.
Latest quarter
- Cash and cash equivalents
- 12 thousand USD Source
Exact value
11989 USD
- Long-term debt including current maturities
- Not available
- Shares outstanding
- 10.2 million shares Source
Exact value
10152284 shares
Trailing twelve months
The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.
Revenue
12.4 thousand USD
2025-07-01 – 2026-06-30
Net income
-1.01 million USD
2025-07-01 – 2026-06-30
Exact inputs and evidence
Includes later revisions to earlier periods. Annual charts exclude incomplete years.
Latest filing recorded: 2026-08-14.
Financial data available through: 2025-12-31.
Coverage by financial measure
- Revenue: 10 of 11 periods available· newest 2025-12-31
- Operating income: 11 of 11 periods available· newest 2025-12-31
- Net income: 11 of 11 periods available· newest 2025-12-31
- Operating cash flow: 11 of 11 periods available· newest 2025-12-31
- Capital expenditure: 4 of 11 periods available· newest 2022-12-31
- Total assets: 10 of 11 periods available· newest 2025-12-31
- Total liabilities: 7 of 11 periods available· newest 2025-12-31
- Current assets: 10 of 11 periods available· newest 2025-12-31
- Current liabilities: 10 of 11 periods available· newest 2025-12-31
- Cash and cash equivalents: 10 of 11 periods available· newest 2025-12-31
- long term debt: No compatible figures in this window
- shares outstanding: No compatible figures in this window
Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.
What changed year over year
Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.
Revenue
+256%Prior period
USD 3,470
–
Current period
USD 12,353
–
Exact inputs and evidence
12353 − 3470 = 8883 USD
3470 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source12353 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Net income
+USD 696,400Prior period
−USD 1.78 million
–
Current period
−USD 1.08 million
–
Exact inputs and evidence
-1079248 − -1775648 = 696400 USD
-1775648 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-1079248 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 494,927Prior period
−USD 1.34 million
–
Current period
−USD 842,802
–
Exact inputs and evidence
-842802 − -1337729 = 494927 USD
-1337729 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source-842802 USD · 2025-01-01 – 2025-12-31
Inspect current input Current sourceShare or cite
The citation records this snapshot. The page link may show a newer release later.
Comparable inputs unavailable for: Capital expenditure.
Where revenue goes
How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.
2025 2025-01-01 – 2025-12-31
- Revenue USD 12,353 100% of revenue
- Cost of revenue USD 4,188 34% of revenue
- Operating expenses USD 1.2 million 9,681% of revenue
- Operating income −USD 1.19 million −9,615% of revenue
- Tax, interest and other Derived −USD 108,448 −878% of revenue
- Net income −USD 1.08 million −8,737% of revenue
Cash
- Operating cash flow −USD 842,802 −6,823% of revenue
- Capital expenditure Unavailable An input is unavailable.
- Free cash flow Derived Unavailable An input is unavailable.
Share of revenue by period
- Net income
- Tax, interest and other
- Operating costs
- 2018 Not shown: operating income or net income is not reported.
- 2019 Not shown: operating income or net income is not reported.
- 2020 Not shown: operating income or net income is not reported.
- 2021 Operating loss: operating costs were 224% of revenue.
- 2022 Operating loss: operating costs were 1,256% of revenue.
- 2023 Operating loss: operating costs were 298% of revenue.
- 2024 Operating loss: operating costs were 51,106% of revenue.
- 2025 Operating loss: operating costs were 9,715% of revenue.
Values and sources
| Period | Revenue | Operating costs | Operating income | Tax, interest and other | Net income | Free cash flow | Source |
|---|---|---|---|---|---|---|---|
| 2018 2017-03-01 – 2018-02-28 | 0 | 58000 Derived | -58000 | 86000 Derived | -144000 | Unavailable | Source
|
| 2019 2018-03-01 – 2019-02-28 | 0 | 48000 Derived | -48000 | 100000 Derived | -148000 | Unavailable | Source
|
| 2020 2019-03-01 – 2020-02-29 | 0 | 29000 Derived | -29000 | 105000 Derived | -134000 | Unavailable | Source
|
| 2021 2021-01-01 – 2021-12-31 | 1244373 | 2787238 Derived | -1542865 | -427 Derived | -1542438 | -1585579 Derived | Source
|
| 2022 2022-01-01 – 2022-12-31 | 104283 | 1309506 Derived | -1205223 | -229 Derived | -1204994 | -600953 Derived | Source
|
| 2023 2023-01-01 – 2023-12-31 | 604676 | 1799382 Derived | -1194706 | 377 Derived | -1195083 | Unavailable | Source
|
| 2024 2024-01-01 – 2024-12-31 | 3470 | 1773389 Derived | -1769919 | 5729 Derived | -1775648 | Unavailable | Source
|
| 2025 2025-01-01 – 2025-12-31 | 12353 | 1200049 Derived | -1187696 | -108448 Derived | -1079248 | Unavailable | Source
|
Amounts are exact, in USD.
Growth
Sales over time and how quickly they are changing.
Revenue
Revenue reported for each complete financial period.
USD 12.4K 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Revenue | 0 |
|
| 2017 | Revenue | 0 |
|
| 2018 | Revenue | 0 |
|
| 2019 | Revenue | 0 |
|
| 2020 | Revenue | 0 |
|
| 2021 | Revenue | 1244373 |
|
| 2022 | Revenue | 104283 |
|
| 2023 | Revenue | 604676 |
|
| 2024 | Revenue | 3470 |
|
| 2025 | Revenue | 12353 |
|
Revenue growth
Change in revenue from the same financial period one year earlier.
256% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Year over year | No prior comparable period |
|
| 2017 | Year over year | No prior comparable period |
|
| 2018 | Year over year | No prior comparable period |
|
| 2019 | Year over year | No prior comparable period |
|
| 2020 | Year over year | No prior comparable period |
|
| 2021 | Year over year | No prior comparable period |
|
| 2022 | Year over year | -91.6% |
|
| 2023 | Year over year | 479.8% |
|
| 2024 | Year over year | -99.4% |
|
| 2025 | Year over year | 256% |
|
Profit and cash
How much revenue becomes profit, and how much cash operations generate.
Profit margins
Operating income, net income and free cash flow as a share of revenue.
Operating margin -9,614.6% 2025
Net margin -8,736.7% 2025
Free cash flow margin -576.3% 2022
- Operating margin
- Net margin
- Free cash flow margin
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016-02-29 | Operating margin | Not reported |
|
| 2017 | Operating margin | Not reported |
|
| 2018 | Operating margin | Not reported |
|
| 2019 | Operating margin | Not reported |
|
| 2020 | Operating margin | Not reported |
|
| 2021 | Operating margin | -124% |
|
| 2022 | Operating margin | -1,155.7% |
|
| 2023 | Operating margin | -197.6% |
|
| 2024 | Operating margin | -51,006.3% |
|
| 2025 | Operating margin | -9,614.6% |
|
| 2016-02-29 | Net margin | Not reported |
|
| 2017 | Net margin | Not reported |
|
| 2018 | Net margin | Not reported |
|
| 2019 | Net margin | Not reported |
|
| 2020 | Net margin | Not reported |
|
| 2021 | Net margin | -124% |
|
| 2022 | Net margin | -1,155.5% |
|
| 2023 | Net margin | -197.6% |
|
| 2024 | Net margin | -51,171.4% |
|
| 2025 | Net margin | -8,736.7% |
|
| 2016 | Free cash flow margin | Not reported |
|
| 2017 | Free cash flow margin | Not reported |
|
| 2018 | Free cash flow margin | Not reported |
|
| 2019 | Free cash flow margin | Not reported |
|
| 2020 | Free cash flow margin | Not reported |
|
| 2021 | Free cash flow margin | -127.4% |
|
| 2022 | Free cash flow margin | -576.3% |
|
| 2023 | Free cash flow margin | Not reported |
|
| 2024 | Free cash flow margin | Not reported |
|
| 2025 | Free cash flow margin | Not reported |
|
Operating cash flow
Cash generated by the company’s normal business operations.
USD -842.8K 2025
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Operating cash flow | Not reported | No source recorded |
| 2017 | Operating cash flow | Not reported | No source recorded |
| 2018 | Operating cash flow | -55000 |
|
| 2019 | Operating cash flow | -32000 |
|
| 2020 | Operating cash flow | -22000 |
|
| 2021 | Operating cash flow | -1020861 |
|
| 2022 | Operating cash flow | -600953 |
|
| 2023 | Operating cash flow | -738971 |
|
| 2024 | Operating cash flow | -1337729 |
|
| 2025 | Operating cash flow | -842802 |
|
Free cash flow
Operating cash flow minus capital expenditure for the same period and unit.
USD -601K 2022
Values and sources
| Period | Series | Value(USD) | Source evidence |
|---|---|---|---|
| 2016 | Free cash flow | Unavailable | No source recorded |
| 2017 | Free cash flow | Unavailable | No source recorded |
| 2018 | Free cash flow | Unavailable |
|
| 2019 | Free cash flow | Unavailable |
|
| 2020 | Free cash flow | Unavailable |
|
| 2021 | Free cash flow | -1585579 |
|
| 2022 | Free cash flow | -600953 |
|
| 2023 | Free cash flow | Unavailable |
|
| 2024 | Free cash flow | Unavailable |
|
| 2025 | Free cash flow | Unavailable |
|
Balance sheet
Liabilities and short-term ability to meet obligations at each period end.
Liabilities to assets
Total liabilities as a share of total assets.
329.5% 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Liabilities / assets | 9,085.7% |
|
| 2017-02-28 | Liabilities / assets | Not reported |
|
| 2018-02-28 | Liabilities / assets | Not reported |
|
| 2019-02-28 | Liabilities / assets | Not reported |
|
| 2020 | Liabilities / assets | 179,900% |
|
| 2021 | Liabilities / assets | 102.9% |
|
| 2022 | Liabilities / assets | 124.1% |
|
| 2023 | Liabilities / assets | 210.6% |
|
| 2024 | Liabilities / assets | 314.9% |
|
| 2025 | Liabilities / assets | 329.5% |
|
Current assets to current liabilities
Current assets divided by current liabilities.
0.24× 2025
Values and sources
| Period | Series | Value | Source evidence |
|---|---|---|---|
| 2016 | Current assets / current liabilities | 0.01× |
|
| 2017 | Current assets / current liabilities | 0× |
|
| 2018 | Current assets / current liabilities | 0× |
|
| 2019 | Current assets / current liabilities | 0× |
|
| 2020 | Current assets / current liabilities | 0× |
|
| 2021 | Current assets / current liabilities | 0.38× |
|
| 2022 | Current assets / current liabilities | 0.3× |
|
| 2023 | Current assets / current liabilities | 0.21× |
|
| 2024 | Current assets / current liabilities | 0.14× |
|
| 2025 | Current assets / current liabilities | 0.24× |
|
Cash generation
Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.
| Period | Net income | Operating cash flow | Capital expenditure | Free cash flow |
|---|---|---|---|---|
| 2018 2017-03-01 – 2018-02-28 | −USD 144,000 Exact valueExact value: -144000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 55,000 Exact valueExact value: -55000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2018-03-01 – 2019-02-28 | −USD 148,000 Exact valueExact value: -148000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 32,000 Exact valueExact value: -32000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2019 2019-01-01 – 2019-12-31 | −USD 231,193 Exact valueExact value: -231193 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 682,121 Exact valueExact value: -682121 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 36,983 Exact valueExact value: 36983 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 719,104 Calculation and evidence-682121 − 36983 USD Exact free cash flow: -719104 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2020 2019-03-01 – 2020-02-29 | −USD 134,000 Exact valueExact value: -134000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 22,000 Exact valueExact value: -22000 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2020 2020-01-01 – 2020-12-31 | −USD 711,801 Exact valueExact value: -711801 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 101,107 Exact valueExact value: 101107 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 42,556 Exact valueExact value: 42556 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 58,551 Calculation and evidence101107 − 42556 USD Exact free cash flow: 58551 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2021 2021-01-01 – 2021-12-31 | −USD 1.54 million Exact valueExact value: -1542438 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.02 million Exact valueExact value: -1020861 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 564,718 Exact valueExact value: 564718 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.59 million Calculation and evidence-1020861 − 564718 USD Exact free cash flow: -1585579 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2022 2022-01-01 – 2022-12-31 | −USD 1.2 million Exact valueExact value: -1204994 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 600,953 Exact valueExact value: -600953 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | USD 0 Exact valueExact value: 0 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 600,953 Calculation and evidence-600953 − 0 USD Exact free cash flow: -600953 USD
Share or citeThe citation records this snapshot. The page link may show a newer release later. |
| 2023 2023-01-01 – 2023-12-31 | −USD 1.2 million Exact valueExact value: -1195083 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 738,971 Exact valueExact value: -738971 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2024 2024-01-01 – 2024-12-31 | −USD 1.78 million Exact valueExact value: -1775648 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 1.34 million Exact valueExact value: -1337729 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
| 2025 2025-01-01 – 2025-12-31 | −USD 1.08 million Exact valueExact value: -1079248 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | −USD 842,802 Exact valueExact value: -842802 USD Share or citeThe citation records this snapshot. The page link may show a newer release later. | Unavailable Not reported for this period. | Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period. |
Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.
Dataset coverage and company identifiers
Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.
126 filings · 2,924 latest values · 2,924 originally reported values
Dataset published . Source filing dates and reporting periods are shown separately.
Identifiers: 0000895464, 895464, YBGJ, edgar:895464
Also known as MAGNA LAB INC, Magna Lab Inc., YUBO INTERNATIONAL BIOTECH LIMITED, Yubo International Biotech Ltd